Cell cycle regulated transcription and control of genome integrity
In plain English
AI plain-English summaryEvery time a cell divides, it must first pass through a molecular gate called G1-phase—and when that gate breaks, cells can start multiplying uncontrollably, forming tumours. This research tackles a fundamental gap in cancer biology: how DNA damage checkpoints, which normally halt cell division when genetic material is faulty, interact with the proteins that control the G1-phase exit. Many of those G1-S control proteins are found mutated in human cancers, suggesting that disabling this pathway helps tumours develop. The researcher has already shown that the G1-S transcriptional network is a target of DNA structure checkpoints. Now they aim to map the precise biochemical interplay between these two systems. This is fundamental science with no immediate clinical application. However, understanding how cells coordinate division with genome surveillance could eventually reveal new drug targets. If researchers can pinpoint how checkpoint failures allow damaged cells to slip through G1-S, they may identify molecular levers to restore that brake. Past work on cell-cycle checkpoints has already produced cancer therapies—such as drugs that exploit checkpoint defects in tumour cells—so a deeper mechanistic picture here could feed into that pipeline.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know